Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | +1.37% | +14.11% | -88.41% |
07-09 | JPMorgan Downgrades HilleVax to Neutral From Overweight, Cuts Price Target to $5 From $24 | MT |
07-09 | Guggenheim Downgrades HilleVax to Neutral From Buy, | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.41% | 86.88M | |
+24.74% | 47.96B | |
+0.43% | 42.45B | |
+43.96% | 41.47B | |
+26.09% | 31.6B | |
+20.41% | 28.63B | |
-4.47% | 28.03B | |
+51.68% | 14.56B | |
+44.78% | 14.14B | |
+2.06% | 12.58B |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- Leerink Partners Downgrades HilleVax to Market Perform From Outperform, Adjusts Price Target to $2 From $28